1ypq: Difference between revisions
m Protected "1ypq" [edit=sysop:move=sysop] |
No edit summary |
||
Line 1: | Line 1: | ||
{{STRUCTURE_1ypq| PDB=1ypq | SCENE= }} | {{STRUCTURE_1ypq| PDB=1ypq | SCENE= }} | ||
===Human Oxidized Low Density Lipoprotein Receptor LOX-1 Dioxane Complex=== | |||
{{ABSTRACT_PUBMED_15695803}} | |||
=== | ==Disease== | ||
[[http://www.uniprot.org/uniprot/OLR1_HUMAN OLR1_HUMAN]] Note=Independent association genetic studies have implicated OLR1 gene variants in myocardial infarction susceptibility.<ref>PMID:12384789</ref><ref>PMID:12807963</ref><ref>PMID:15060104</ref><ref>PMID:15276231</ref><ref>PMID:15860461</ref> Note=OLR1 may be involved in Alzheimer disease (AD). Involvement in AD is however unclear: according to some authors (PubMed:12354387, PubMed:12810610 and PubMed:15976314), variations in OLR1 modify the risk of AD, while according to other (PubMed:15000751 and PubMed:15060104) they do not.<ref>PMID:12384789</ref><ref>PMID:12807963</ref><ref>PMID:15060104</ref><ref>PMID:15276231</ref><ref>PMID:15860461</ref> | |||
==Function== | |||
[[http://www.uniprot.org/uniprot/OLR1_HUMAN OLR1_HUMAN]] Receptor that mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (oxLDL) by vascular endothelial cells. OxLDL is a marker of atherosclerosis that induces vascular endothelial cell activation and dysfunction, resulting in pro-inflammatory responses, pro-oxidative conditions and apoptosis. Its association with oxLDL induces the activation of NF-kappa-B through an increased production of intracellular reactive oxygen and a variety of pro-atherogenic cellular responses including a reduction of nitric oxide (NO) release, monocyte adhesion and apoptosis. In addition to binding oxLDL, it acts as a receptor for the HSP70 protein involved in antigen cross-presentation to naive T-cells in dendritic cells, thereby participating in cell-mediated antigen cross-presentation. Also involved in inflammatory process, by acting as a leukocyte-adhesion molecule at the vascular interface in endotoxin-induced inflammation. Also acts as a receptor for advanced glycation end (AGE) products, activated platelets, monocytes, apoptotic cells and both Gram-negative and Gram-positive bacteria.<ref>PMID:9052782</ref><ref>PMID:11821063</ref><ref>PMID:12354387</ref> | |||
==About this Structure== | ==About this Structure== | ||
Line 11: | Line 13: | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:015695803</ref><references group="xtra"/> | <ref group="xtra">PMID:015695803</ref><references group="xtra"/><references/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Adsit, F G.]] | [[Category: Adsit, F G.]] |